Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
Immunotherapy and Immunoprevention

Mine Özcan, PhD

Postdoctoral Scientist

Scientific CV

Feb - Nov 2018
Postdoctoral scientist, Junior Research Group Immunotherapy and Immunoprevention, DKFZ, Heidelberg

2014 - 2017
PhD student, Applied Tumor Biology, DKFZ, Heidelberg

2012 - 2014
MSc Biology, Graduate School of Natural and Applied Sciences, Middle East Technical University, Ankara, Turkey

2008 - 2012
BSc Biology, Department of Biology, Middle East Technical University, Ankara, Turkey

Research Project

Immunological causes for radiosensitivity of HPV-driven HNSCC

HPV-driven head and neck squamous cell carcinomas (HNSCCs) constitute 80% of oropharyngeal squamous cell carcinomas. They are characterized by a significant survival advantage over HPV-negative HNSCCs. In addition to better overall survival, HPV+ HNSCCs are more sensitive to irradiation than their HPV-negative counterparts. The main goal of this project was to determine if there is a link between the increased radiosensitivity of HPV-driven HNSCC and a possible elevated presentation of HPV-encoded and/or mutation-derived neoepitopes following irradiation as compared to HPV-negative HNSCCs.

Resulting Publications

Enhanced radiation sensitivity of human papillomavirus-driven head and neck cancer: focus on immunological aspects.
Özcan-Wahlbrink M, Schifflers C, Riemer AB.
Frontiers in Immunology 2019, 10: 2831

to top
powered by webEdition CMS